Cargando…
Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218406/ https://www.ncbi.nlm.nih.gov/pubmed/34154617 http://dx.doi.org/10.1186/s12967-021-02916-0 |
_version_ | 1783710758143524864 |
---|---|
author | Moon, Jeonghyeon Lee, Seon-yeong Choi, Jeong Won Lee, A. Ram Yoo, Jin Hee Moon, Su-Jin Park, Sung-Hwan Cho, Mi-La |
author_facet | Moon, Jeonghyeon Lee, Seon-yeong Choi, Jeong Won Lee, A. Ram Yoo, Jin Hee Moon, Su-Jin Park, Sung-Hwan Cho, Mi-La |
author_sort | Moon, Jeonghyeon |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8218406 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-82184062021-06-23 Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts Moon, Jeonghyeon Lee, Seon-yeong Choi, Jeong Won Lee, A. Ram Yoo, Jin Hee Moon, Su-Jin Park, Sung-Hwan Cho, Mi-La J Transl Med Correction BioMed Central 2021-06-21 /pmc/articles/PMC8218406/ /pubmed/34154617 http://dx.doi.org/10.1186/s12967-021-02916-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correction Moon, Jeonghyeon Lee, Seon-yeong Choi, Jeong Won Lee, A. Ram Yoo, Jin Hee Moon, Su-Jin Park, Sung-Hwan Cho, Mi-La Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts |
title | Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts |
title_full | Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts |
title_fullStr | Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts |
title_full_unstemmed | Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts |
title_short | Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts |
title_sort | correction to: metformin ameliorates scleroderma via inhibiting th17 cells and reducing mtor-stat3 signaling in skin fibroblasts |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218406/ https://www.ncbi.nlm.nih.gov/pubmed/34154617 http://dx.doi.org/10.1186/s12967-021-02916-0 |
work_keys_str_mv | AT moonjeonghyeon correctiontometforminamelioratessclerodermaviainhibitingth17cellsandreducingmtorstat3signalinginskinfibroblasts AT leeseonyeong correctiontometforminamelioratessclerodermaviainhibitingth17cellsandreducingmtorstat3signalinginskinfibroblasts AT choijeongwon correctiontometforminamelioratessclerodermaviainhibitingth17cellsandreducingmtorstat3signalinginskinfibroblasts AT leearam correctiontometforminamelioratessclerodermaviainhibitingth17cellsandreducingmtorstat3signalinginskinfibroblasts AT yoojinhee correctiontometforminamelioratessclerodermaviainhibitingth17cellsandreducingmtorstat3signalinginskinfibroblasts AT moonsujin correctiontometforminamelioratessclerodermaviainhibitingth17cellsandreducingmtorstat3signalinginskinfibroblasts AT parksunghwan correctiontometforminamelioratessclerodermaviainhibitingth17cellsandreducingmtorstat3signalinginskinfibroblasts AT chomila correctiontometforminamelioratessclerodermaviainhibitingth17cellsandreducingmtorstat3signalinginskinfibroblasts |